Jonas has been focused on the commercialization of life science innovation for about 20 years. Between 2001 and 2010, Jonas was the CEO of Cogmed, a start-up in the field of evidence-based cognitive training (clinically validated software), based in Stockholm and later in the US. Cogmed came out of Karolinska Innovation and was the first Karolinska Development portfolio company to be sold. Jonas took the company from the research phase at the Karolinska Institute in 2001, to acquisition by Pearson, in 2010.
Before joining Industrifonden in 2017, Jonas also held various advisor and board member roles, in both early stage and public companies, and across digital health (such as Shim, acquired by Kry), medtech and biotech (such as Bioinvent). His background also includes strategy work with The Boston Consulting Group.
Jonas holds a M.Sc. from the Stockholm School of Economics.